A magnetic cross-linked alginate-biobased nanocomposite with anticancer and hyperthermia activities

This research study focuses on a new magnetic nanobiocomposite designed and synthesized by the formation of cross-linked alginate (Alg) hydrogel using CaCl2 cross-linker agent, its modification with flaxseed mucilage hydrogel and silk fibroin (SF) biopolymer extracted, and as well, the in-situ synthesis of Fe3O4 magnetic nanoparticles (Fe3O4 MNPs) in the presence of this biopolymeric substrate. FT-IR, EDX, FE-SEM, XRD, VSM, and TG technical analyses clarified the physical and chemical features of magnetic cross-linked Alg/flaxseed mucilage hydrogel/SF nanobiocomposite. Following the structural characterization of this magnetic natural-based composition, the in-vitro cytotoxicity and hemolysis assay studies with different concentrations resulted in prominent biological outcomes. The survival rates of normal HEK293T cells (95.74%, 94.18%) and breast cancer BT549 cells (79.23%, 77.76%) after 48 and 72 h verified the biocompatibility and anticancer properties of this new nanobiocomposite. Also, less than 5% of the hemolytic effect disclosed its hemocompatibility. Furthermore, a high specific absorption rate value (72.42 W/g) is generated by 1 mg/mL of this magnetic nanobiocomposite. Overall, it can be deduced that magnetic responsive cross-linked Alg/flaxseed mucilage hydrogel/SF nanobiocomposite could functionally perform in magnetic hyperthermia treatment.